Harsini S, Soleimani M, Wilson D, Uribe C, et al. A Phase I/II Study of [(177)Lu]Lu-HTK03170 with Personalized Dosimetry in Patients with Metastatic Castration-Resistant Prostate Cancer: Clinical Trial Protocol. J Nucl Med 2025 Apr 30:jnumed.124.269064. doi: 10.2967/jnumed.124.269064.
PMID: 40306965